Efficacy and Safety of a New Sperm Capacitation Method

Recruiting now

Conditions studied: Reproductive Issues, Male Infertility, Asthenozoospermia, Oligozoospermia, Teratozoospermia

In brief

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Key facts

Study ID

NCT06742437

Run by

Fecundis Lab SL

People needed

300

Starts

2025-01-14

Expected to finish

2026-06-01

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older, up to 60. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Ability to provide a semen sample via masturbation

You may not qualify if…

• Current diagnosis of a sexually transmitted infection (STI)
• Previous diagnosis of hepatitis A, B, C, D, or HIV
• Prior participation in this study
• Participation in a clinical trial involving an intervention within the last 3 months

Where it is running

• Eugin Barcelona — Barcelona, Barcelona, Spain (enrolling)
• Fertty — Barcelona, Barcelona, Spain (enrolling)
• CIRH — Barcelona, Barcelona, Spain (enrolling)
• Natuvitro — Barcelona, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.